Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients
NCT ID: NCT00137670
Last Updated: 2012-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45000 participants
INTERVENTIONAL
2002-04-30
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention trial was designed to develop and evaluate a video-based HIV/STD prevention intervention for STD clinic clients. The primary goals of this study are to assess whether a brief video-based educational waiting room intervention can reduce STD incidence (STD incidence outcome study) and high risk behavior (behavioral outcome study) among male and female patients attending STD clinics, when compared with patients who receive standard clinic services. This study is being conducted as a multi-site trial in 3 urban STD clinics.
The intervention condition consists of a 23-minute educational video focused on preventing STD and HIV infection shown on a large television in the waiting room. Health promotion posters supplement the video. The control condition consists of the current standard waiting room experience in each city's STD clinic.
In the STD incidence outcome study, groups of patients attending the participating STD clinics are randomly assigned to blocks of clinic weeks to either the intervention or control condition. A waiver of informed consent was obtained whereby no subjects are actively enrolled for this phase of the study. Through a retrospective review of existing medical records and STD surveillance registry data, we will determine and compare the incidence of new STDs over a 12-month period (on average) by assigned waiting room conditions.
In the behavioral outcome study, investigators administer computer-based survey instruments to a random sample of \~1600 male and female patients (800 per arm) both at enrollment and at 3 months following their initial clinic visit. The primary objective of the behavioral study is to assess the effectiveness of the video intervention by comparing levels of high-risk behavior between waiting room conditions at 3 months' follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video-based HIV/STD prevention intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All medical records for STD clinic patients visiting participating STD clinics during the study period.
Behavioral Outcome Study:
STD clinic patients:
* Not returning for a follow-up visit related to a previously diagnosed problem.
* 18 years of age or older.
* Not known to be HIV-infected by self-report.
* Able to understand and speak English fluently.
* Have not been previously seen as a patient in the clinic during an intervention block when the video was being played.
* Have never received a diagnosis of a condition that necessitates frequent return visits (e.g., genital warts) by self-report.
* Have not previously enrolled in the study.
* Reported being in the clinic waiting room at least 20 minutes.
* Do not plan to move outside the clinic's catchment area during the next 6 months.
* Are willing to provide informed consent for review of their medical record and STD surveillance registry information by study staff.
* Are not known to be pregnant according to self-report (women only).
* Are not known by clinicians or counselors to be seriously ill (e.g. new HIV diagnosis or severe pelvic inflammatory disease \[PID\]).
* Engaged in intercourse in the last three months.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeff D Klausner, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
San Francisco Department of Public Health/ STD Prevention and Control Services
Cornelis A Rietmeijer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Denver Public Health
Kevin Malotte, DrPH
Role: PRINCIPAL_INVESTIGATOR
California State University, Long Beach
Lydia N O'Donnell, Ed.D.
Role: PRINCIPAL_INVESTIGATOR
Education Development Center, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
California State University, Long Beach
Long Beach, California, United States
San Francisco Department of Public Health
San Francisco, California, United States
Denver Public Health
Denver, Colorado, United States
Education Development Center, Inc.
Newton, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gallo MF, Margolis AD, Malotte CK, Rietmeijer CA, Klausner JD, O'Donnell L, Warner L; Safe in the City Study Group. Sexual abstinence and other behaviours immediately following a new STI diagnosis among STI clinic patients: Findings from the Safe in the City trial. Sex Transm Infect. 2016 May;92(3):206-10. doi: 10.1136/sextrans-2014-051982. Epub 2015 Dec 15.
Warner L, Klausner JD, Rietmeijer CA, Malotte CK, O'Donnell L, Margolis AD, Greenwood GL, Richardson D, Vrungos S, O'Donnell CR, Borkowf CB; Safe in the City Study Group. Effect of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics. PLoS Med. 2008 Jun 24;5(6):e135. doi: 10.1371/journal.pmed.0050135.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R18/CCR921007
Identifier Type: -
Identifier Source: secondary_id
R18/CCR121005
Identifier Type: -
Identifier Source: secondary_id
R18/CCR821004
Identifier Type: -
Identifier Source: secondary_id
CDC-NCHSTP-3500
Identifier Type: -
Identifier Source: org_study_id